| Date | Time | Source | Headline | Symbol | Company |
| 06/15/2021 | 2:33PM | Alliance News |  EXECUTIVE CHANGES: Keywords Studies CEO Day retires after 12 years | LSE:MXCT | Maxcyte Inc |
| 06/15/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Maxcyte Appoints Two New Non-Executive Directors | LSE:MXCT | Maxcyte Inc |
| 06/02/2021 | 4:18AM | UK Regulatory | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 05/25/2021 | 2:40PM | Alliance News | TRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry | LSE:MXCT | Maxcyte Inc |
| 05/25/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Signing of Strategic Platform Licence | LSE:MXCT | Maxcyte Inc |
| 05/14/2021 | 9:13AM | Alliance News | IN BRIEF: MaxCyte prepares for listing in New York | LSE:MXCT | Maxcyte Inc |
| 05/14/2021 | 2:00AM | PR Newswire (US) | Proposed Dual-Listing on Nasdaq | LSE:MXCT | Maxcyte Inc |
| 05/14/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Proposed Dual-Listing on Nasdaq | LSE:MXCT | Maxcyte Inc |
| 05/13/2021 | 2:16PM | Alliance News | IN BRIEF: MaxCyte to consolidate two lines of common stock into one | LSE:MXCT | Maxcyte Inc |
| 05/13/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Consolidation of Trading Lines | LSE:MXCT | Maxcyte Inc |
| 04/20/2021 | 7:08AM | Alliance News | TRADING UPDATES: Zegona profit sinks; Flowtech Fluidpower suffers loss | LSE:MXCT | Maxcyte Inc |
| 04/20/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Full Year Results | LSE:MXCT | Maxcyte Inc |
| 04/15/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Notice of Full Year Results | LSE:MXCT | Maxcyte Inc |
| 04/01/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 03/11/2021 | 10:01AM | UK Regulatory | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 03/03/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 02/23/2021 | 2:00AM | RNS Non-Regulatory | MaxCyte, Inc. Participation in Upcoming Investor Conferences | LSE:MXCT | Maxcyte Inc |
| 02/19/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Director Dealings and Issue of Equity | LSE:MXCT | Maxcyte Inc |
| 02/17/2021 | 12:44PM | UK Regulatory | MaxCyte, Inc. Grant of Options | LSE:MXCT | Maxcyte Inc |
| 02/15/2021 | 11:32AM | UK Regulatory | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 02/12/2021 | 8:59AM | UK Regulatory | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 02/08/2021 | 9:59AM | UK Regulatory | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 02/05/2021 | 4:01AM | UK Regulatory | MaxCyte, Inc. Price Monitoring Extension | LSE:MXCT | Maxcyte Inc |
| 02/04/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. CORRECTION: MaxCyte Announces GBP40m Subscription | LSE:MXCT | Maxcyte Inc |
| 02/04/2021 | 2:00AM | UK Regulatory | MaxCyte, Inc. Director Dealings and Issue of Equity | LSE:MXCT | Maxcyte Inc |
| 02/03/2021 | 4:38PM | Alliance News | IN BRIEF: GBP40 Million MaxCyte Subscription Ahead Of Dual Listing | LSE:MXCT | Maxcyte Inc |
| 02/03/2021 | 11:37AM | Alliance News | *MaxCyte Plans GBP40M Subscription Via Private Placement At 700p Per Share | LSE:MXCT | Maxcyte Inc |
| 02/03/2021 | 11:36AM | UK Regulatory | MaxCyte, Inc. MaxCyte Announces GBP40 million Subscription | LSE:MXCT | Maxcyte Inc |
| 02/03/2021 | 11:35AM | UK Regulatory | MaxCyte, Inc. Appointment of Joint Corporate Broker | LSE:MXCT | Maxcyte Inc |
| 01/21/2021 | 9:49AM | UK Regulatory | MaxCyte, Inc. Increase to Block Listing | LSE:MXCT | Maxcyte Inc |